Checkpoint Inhibitors Checkpoint inhibitors have shown promise in treating mesothelioma by blocking proteins that prevent the immune system from attacking cancer cells. These drugs, such as pembrolizumab and nivolumab, help to reactivate the immune response against tumors. Key benefits include: Enhanced immune system activity Potential for long-term remission Improved survival rates CAR-T Cell Therapy Chimeric Antigen Receptor (CAR) T-cell therapy involves modifying a patient’s T-cells … Continue reading Mesothelioma Treatment Advancements: New Hope for Patients